Scrip    Clinica    Scrip Regulatory Affairs    Scrip Clinical Research    AnimalPharm   
Email ID
Password
Forgotten your password?
Sign me in automatically next time
Home
Therapy Sector
Generics
Business
Policy & Regulation
Research & Development
International
News
|
Comment
|
Features
|
Analysis
|
Market Data
|
People
|
Events
|
Multimedia
|
Science Abstracts
Emerging oral drugs for multiple sclerosis
September 2008

Authors : Claudio Gasperini†1 , Luca Ausili Cefaro2 , Giovanna Borriello2 , Giuseppe Tosto3 , Luca Prosperini2 , Carlo Pozzilli1,2

Affliation :

1S Camillo-Forlanini Hospital, Department of Neuroscience, Viale dell'Università 30, 00185 Rome, Italy ; ; carlo.pozzilli@uniroma1.it

2Ospedale S. Andrea, Centro Sclerosi Multipla, Roma, Italy

3Policlinico Umberto I, Centro Sclerosi Multipla, Roma, Italy

DOI : 10.1517/14728214.13.3.465

Published in : Expert Opin. Emerging Drugs Volume 13 Issue 3 2008 pages 465 477

Subject:

Keywords: cladribrine , fingolimod , fumaric acid , laquinomid , multiple sclerosis , oral treatment , teriflunomide

 
Abstract

Background: Therapy for multiple...

 

Please Login to read the full article.
 
RELATED CONTENT
NEWS Scrip News Other Informa News
ANALYSIS Scrip Analysis Other Informa Analysis
COMMENT Scrip Comment Other Informa Comment
FEATURES Scrip Features Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK Promote your vacancy here
© 2012 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36
Terms & Conditions
Privacy Policy
Sitemap
About Us
Advertise
Subscribe
Scrip
Clinica
Scrip Regulatory Affairs
Scrip Clinical Research
Animal Pharm